These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 10891427)
1. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Salcedo R; Ponce ML; Young HA; Wasserman K; Ward JM; Kleinman HK; Oppenheim JJ; Murphy WJ Blood; 2000 Jul; 96(1):34-40. PubMed ID: 10891427 [TBL] [Abstract][Full Text] [Related]
2. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. Salcedo R; Young HA; Ponce ML; Ward JM; Kleinman HK; Murphy WJ; Oppenheim JJ J Immunol; 2001 Jun; 166(12):7571-8. PubMed ID: 11390513 [TBL] [Abstract][Full Text] [Related]
3. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Bernardini G; Spinetti G; Ribatti D; Camarda G; Morbidelli L; Ziche M; Santoni A; Capogrossi MC; Napolitano M Blood; 2000 Dec; 96(13):4039-45. PubMed ID: 11110671 [TBL] [Abstract][Full Text] [Related]
4. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Ribatti D; Presta M; Vacca A; Ria R; Giuliani R; Dell'Era P; Nico B; Roncali L; Dammacco F Blood; 1999 Apr; 93(8):2627-36. PubMed ID: 10194442 [TBL] [Abstract][Full Text] [Related]
5. Expression of CCR2 by endothelial cells : implications for MCP-1 mediated wound injury repair and In vivo inflammatory activation of endothelium. Weber KS; Nelson PJ; Gröne HJ; Weber C Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2085-93. PubMed ID: 10479649 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody. Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172 [TBL] [Abstract][Full Text] [Related]
8. The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Liu JM; Lawrence F; Kovacevic M; Bignon J; Papadimitriou E; Lallemand JY; Katsoris P; Potier P; Fromes Y; Wdzieczak-Bakala J Blood; 2003 Apr; 101(8):3014-20. PubMed ID: 12480715 [TBL] [Abstract][Full Text] [Related]
9. Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Ali S; Palmer AC; Fritchley SJ; Maley Y; Kirby JA Biochem J; 2001 Sep; 358(Pt 3):737-45. PubMed ID: 11535134 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434 [TBL] [Abstract][Full Text] [Related]
12. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437 [TBL] [Abstract][Full Text] [Related]
13. Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Lee MS; Moon EJ; Lee SW; Kim MS; Kim KW; Kim YJ Cancer Res; 2001 Apr; 61(8):3290-3. PubMed ID: 11309282 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells. Wild R; Dhanabal M; Olson TA; Ramakrishnan S Br J Cancer; 2000 Oct; 83(8):1077-83. PubMed ID: 10993657 [TBL] [Abstract][Full Text] [Related]
15. Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1. Wang S; Xu M; Li F; Wang X; Bower KA; Frank JA; Lu Y; Chen G; Zhang Z; Ke Z; Shi X; Luo J Breast Cancer Res Treat; 2012 Jun; 133(3):1037-48. PubMed ID: 22160640 [TBL] [Abstract][Full Text] [Related]
16. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function. Spinetti G; Wang M; Monticone R; Zhang J; Zhao D; Lakatta EG Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1397-402. PubMed ID: 15178559 [TBL] [Abstract][Full Text] [Related]
17. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. Hetian L; Ping A; Shumei S; Xiaoying L; Luowen H; Jian W; Lin M; Meisheng L; Junshan Y; Chengchao S J Biol Chem; 2002 Nov; 277(45):43137-42. PubMed ID: 12183450 [TBL] [Abstract][Full Text] [Related]
18. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide. Kim MY; Byeon CW; Hong KH; Han KH; Jeong S FEBS Lett; 2005 Mar; 579(7):1597-601. PubMed ID: 15757647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]